Olmesartan Medoxomil Tablets IP MANUFACTURERS SUPPLIERS - THIRD PARTY CONTRACT MANUFACTURING - PCD PHARMA FRANCHISE
Olmesartan Medoxomil Tablets IP are a medication provided by DR.D Pharma. Olmesartan Medoxomil is the active ingredient in these tablets and is classified as an angiotensin II receptor antagonist, commonly used in the management of hypertension (high blood pressure).
These tablets are formulated to help regulate blood pressure by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure. By inhibiting angiotensin II, Olmesartan Medoxomil promotes the dilation of blood vessels, thereby reducing blood pressure and improving blood flow.
The primary indication for Olmesartan Medoxomil Tablets IP is the treatment of hypertension in adult patients. High blood pressure is a significant risk factor for cardiovascular diseases such as heart attacks and strokes. By effectively controlling blood pressure, these tablets can help lower the risk of these potentially life-threatening conditions.
The recommended dosage of Olmesartan Medoxomil Tablets IP should be determined by a healthcare professional based on individual patient factors. It is important to follow the prescribed dosage and any accompanying instructions provided by the healthcare provider or mentioned on the product packaging.
As with any medication, Olmesartan Medoxomil Tablets IP may have potential side effects. Common side effects can include dizziness, headache, diarrhea, back pain, and upper respiratory tract infections. It is important to consult with a healthcare professional if any side effects persist or worsen.
It is crucial to note that this description is for informational purposes only and should not replace professional medical advice. Individuals considering or currently using Olmesartan Medoxomil Tablets IP should consult their healthcare provider for personalized guidance and information specific to their health condition.